Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000480589 | SCV000567348 | pathogenic | not provided | 2024-12-03 | criteria provided, single submitter | clinical testing | Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); Has not been previously published as pathogenic or benign to our knowledge; This variant is associated with the following publications: (PMID: 11854177, 37686092) |
Labcorp Genetics |
RCV001038349 | SCV001201815 | pathogenic | PTEN hamartoma tumor syndrome | 2020-10-21 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. This sequence change creates a premature translational stop signal (p.Asn292Metfs*15) in the PTEN gene. It is expected to result in an absent or disrupted protein product. This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals with PTEN-related conditions. ClinVar contains an entry for this variant (Variation ID: 419505). Loss-of-function variants in PTEN are known to be pathogenic (PMID: 9467011, 21194675). |
Myriad Genetics, |
RCV003449194 | SCV004189589 | pathogenic | Cowden syndrome 1 | 2023-10-02 | criteria provided, single submitter | clinical testing | This variant is considered pathogenic. This variant creates a frameshift predicted to result in premature protein truncation. |